Editorial: PSC as an Independent Risk Factor for CRC Without IBD: Can Observed Epidemiological Trends Help Uncover Biological Mechanisms and Guide Surveillance Strategies?

IF 6.7 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2025-08-20 DOI:10.1111/apt.70325

Natassia Tan, Kristel Leung

引用次数: 0

查看原文本刊更多论文

评论：PSC作为结直肠癌无IBD的独立危险因素：观察到的流行病学趋势是否有助于揭示生物学机制并指导监测策略？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.